SAVANNA FARRIS BROUSSARD: Open Payments
NPI 1144797952 · METAIRIE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,148 in 125 payments from 17 companies in 2025. Trend: 2023 $2,186 · 2024 $1,290 · 2025 $2,148
Food & beverage: $2,064Education: $84
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 24 | $625 |
| ABBVIE INC. | 36 | $523 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $162 |
| Ipsen Biopharmaceuticals, Inc | 8 | $158 |
| Phathom Pharmaceuticals, Inc. | 18 | $144 |
| Ardelyx, Inc. | 6 | $117 |
| Madrigal Pharmaceuticals | 4 | $74 |
| Lilly USA, LLC | 4 | $74 |
| QOL Medical, LLC | 3 | $70 |
| GENZYME CORPORATION | 2 | $45 |
Products named: TREMFYA, SKYRIZI, RINVOQ, IQIRVO, VOQUEZNA, ENTYVIO, IBSRELA, REZDIFFRA.
Industry payments across LA — which companies pay providers there.
